Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 5/20 | 0.37 |
| ▸ | MMP9 | P14780 | 5/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | MMP3 | P08254 | 1/20 | 0.35 |
| ▸ | MMP8 | P22894 | 2/20 | 0.34 |
| ▸ | MMP13 | P45452 | 2/20 | 0.34 |
| ▸ | NAAA | Q02083 | 1/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4181879 | 1.00 | MMP2 (0.37) | MMP2MMP9EPHX1ALDH1A1HTT | |
| SCHEMBL9746020 | 1.00 | MMP2 (0.37) | MMP2MMP9EPHX1ALDH1A1HTT | |
| SCHEMBL4184929 | 1.00 | MMP2 (0.37) | MMP2MMP9EPHX1ALDH1A1HTT | |
| SCHEMBL10440677 | 1.00 | MMP2 (0.37) | MMP2MMP9EPHX1ALDH1A1HTT | |
| Hydrochloric Acid SCHEMBL9852429 | 0.99 | MMP2 (0.36) | MMP2MMP9EPHX1ALDH1A1HTT | |
| SCHEMBL27902585 | 0.99 | MMP2 (0.35) | MMP2MMP9EPHX1ALDH1A1HTT | |
| SCHEMBL28625433 | 0.95 | HPGD (0.33) | EPHX1ALDH1A1HTTSOAT1CES2 | |
| SCHEMBL8780388 | 0.91 | MMP2 (0.36) | MMP2MMP9SOAT1CES2CES1 | |
| SCHEMBL7510602 | 0.89 | SMN1; SMN2 (0.33) | ALDH1A1 | |
| SCHEMBL10429680 | 0.89 | MMP2 (0.40) | MMP2MMP9ALDH1A1SOAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105969404-B | Liquid crystal aligning agent, liquid crystal alignment film formed by liquid crystal aligning agent and liquid crystal display element | 奇美实业股份有限公司 | 2018-03-23 | — | — | CN | disclosed |
| CN-105969404-A | Liquid crystal aligning agent, liquid crystal alignment film formed by liquid crystal aligning agent and liquid crystal display element | 奇美实业股份有限公司 | 2016-09-28 | — | — | CN | disclosed |
| CN-105567257-A | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | CHI MEI CORP | 2016-05-11 | — | — | CN | disclosed |
| CN-103571502-B | Crystal aligning agent and compound | JSR CO., LTD. (JP) | 2016-05-04 | — | — | CN | disclosed |
| CN-103374353-B | The manufacture method of crystal aligning agent, liquid crystal orienting film, liquid crystal display device and liquid crystal display device | JSR CO., LTD. (JP) | 2016-01-20 | — | — | CN | disclosed |
| CN-103131431-B | MATERIALS FOR DISPLAY, crystal aligning agent and liquid crystal display device | JSR CO., LTD. (JP) | 2015-10-07 | — | — | CN | disclosed |
| CN-102311739-B | The manufacture method of liquid crystal aligning agent, liquid crystal display device and liquid crystal display device | JSR CO., LTD. (JP) | 2015-09-16 | — | — | CN | disclosed |
| CN-103788962-A | Liquid crystal aligning agent for PSA mode liquid crystal display device, liquid crystal alignment film for PSA mode liquid crystal display device, and the PSA mode liquid crystal display device and manufacturing method thereof | JSR CORP | 2014-05-14 | — | — | CN | disclosed |
| CN-103571502-A | Liquid crystal aligning agent and compound | JSR CORP | 2014-02-12 | — | — | CN | disclosed |
| CN-103525435-A | Liquid crystal aligning agent, manufacturing method for liquid crystal display device, liquid crystal alignment film, liquid crystal display device, polymer and carboxylic acid | JSR CORP | 2014-01-22 | — | — | CN | disclosed |
| CN-103374353-A | Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element and manufacturing method for liquid crystal display element | JSR CORP | 2013-10-30 | — | — | CN | disclosed |
| CN-103131431-A | Display material, liquid crystal alignment agent and liquid crystal display element | JSR CORP | 2013-06-05 | — | — | CN | disclosed |
| CN-102311739-A | The method of manufacture of liquid crystal aligning agent, liquid crystal display device and liquid crystal display device | JSR CORP | 2012-01-11 | — | — | CN | disclosed |
| US-20090176837-A1 | COMPOUNDS WITH ACTIVITY AT RETINOIC ACID RECEPTORS | SONY CORPORATION (JP) | 2009-07-09 | — | — | US | disclosed |
| EP-1907347-A2 | COMPOUNDS WITH ACTIVITY AT RETINOIC ACID RECEPTORS | Arcadia Pharmaceuticals Inc. (US) | 2008-04-09 | — | — | EP | disclosed |
| WO-2007009083-A2 | COMPOUNDS WITH ACTIVITY AT RETINOIC ACID RECEPTORS | ACADIA PHARMACEUTICALS INC. (US) | 2007-01-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176837-A1 | COMPOUNDS WITH ACTIVITY AT RETINOIC ACID RECEPTORS | RARB, RARA, RARG | MMP2 2497/4885MMP9 2089/4885EPHX1 1201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.